Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value: $145M (100.0% shares, 0.0% debt)

Holdings (25)

LGND LIGAND PHARMACEUTICALS 13.2%
Value $19.12M Shares 167,487 Share Price $114.15 * Est. Cost/Share $75.54 Unrealized @ Report Date -2.5%
VNDA VANDA PHARMACEUTICALS INC 13.0%
Value $18.91M Shares 1,341,943 Share Price $14.09 * Est. Cost/Share $21.07 Unrealized @ Report Date -24.5%
— AMARIN CORP PLC -ADR 12.4%
Value $18.04M Shares 930,604 Share Price $19.39 Est. Cost/Share $3.01 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL 8.9%
Value $12.86M Shares 2,764,475 Share Price $4.65 Est. Cost/Share $3.48 Unrealized @ Report Date —
— ADAMAS PHARMACEUTICALS INC 6.1%
Value $8.826M Shares 1,423,578 Share Price $6.20 Est. Cost/Share $6.83 Unrealized @ Report Date —
— APOLLO ENDOSURGERY INC 5.8%
Value $8.387M Shares 2,580,518 Share Price $3.25 Est. Cost/Share $4.60 Unrealized @ Report Date —
— NEOS THERAPEUTICS INC 4.4%
Value $6.413M Shares 4,971,014 Share Price $1.29 Est. Cost/Share $1.82 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 3.9%
Value $5.731M Shares 6,439,498 Share Price $0.89 Est. Cost/Share $1.18 Unrealized @ Report Date —
CPIX CUMBERLAND PHARMACEUTICALS 3.8%
Value $5.553M Shares 871,762 Share Price $6.37 * Est. Cost/Share $5.84 Unrealized @ Report Date +3.9%
ENTA ENANTA PHARMACEUTICALS INC 3.8%
Value $5.526M Shares 65,484 Share Price $84.39 * Est. Cost/Share $89.72 Unrealized @ Report Date +0.3%
— IVERIC BIO INC 3.7%
Value $5.348M Shares 4,113,522 Share Price $1.30 Est. Cost/Share $1.30 Unrealized @ Report Date —
— HTG MOLECULAR DIAGNOSTICS 3.2%
Value $4.624M Shares 2,785,585 Share Price $1.66 Est. Cost/Share $2.67 Unrealized @ Report Date —
— OPIANT PHARMACEUTICALS INC 2.9%
Value $4.18M Shares 315,468 Share Price $13.25 Est. Cost/Share $16.03 Unrealized @ Report Date —
XOMA XOMA CORP 2.8%
Value $4.019M Shares 270,449 Share Price $14.86 Est. Cost/Share $13.89 Unrealized @ Report Date +8.1%
— APTEVO THERAPEUTICS INC 2.4%
Value $3.478M Shares 3,922,891 Share Price $0.89 Est. Cost/Share $0.90 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 2.3%
Value $3.355M Shares 3,904,400 Share Price $0.86 Est. Cost/Share $3.06 Unrealized @ Report Date —
— OXFORD IMMUNOTEC GLOBAL PLC 2.2%
Value $3.136M Shares 227,900 Share Price $13.76 Est. Cost/Share $15.14 Unrealized @ Report Date —
— AFFIMED NV 1.4%
Value $2.054M Shares 715,754 Share Price $2.87 Est. Cost/Share $3.04 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 1.1%
Value $1.55M Shares 651,211 Share Price $2.38 Est. Cost/Share $4.50 Unrealized @ Report Date —
— VIVEVE MEDICAL INC 0.9%
Value $1.293M Shares 3,403,402 Share Price $0.38 Est. Cost/Share $6.92 Unrealized @ Report Date —
— INTERPACE DIAGNOSTICS GROUP 0.9%
Value $1.271M Shares 1,753,184 Share Price $0.72 Est. Cost/Share $0.79 Unrealized @ Report Date —
— MATINAS BIOPHARMA HOLDINGS I 0.4%
Value $573K Shares 668,615 Share Price $0.86 Est. Cost/Share $1.09 Unrealized @ Report Date —
— STRONGBRIDGE BIOPHARMA PLC 0.3%
Value $508K Shares 162,244 Share Price $3.13 Est. Cost/Share $4.98 Unrealized @ Report Date —
— NOVELION THERAPEUTICS INC 0.3%
Value $383K Shares 491,096 Share Price $0.78 Est. Cost/Share $0.78 Unrealized @ Report Date —
— MOTUS GI HOLDINGS INC 0.1%
Value $107K Shares 35,205 Share Price $3.04 Est. Cost/Share $3.04 Unrealized @ Report Date —